Jue Tian
Shanxi Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jue Tian.
International Journal of Cardiology | 2011
Lin Zuo; Haijun Bao; Jue Tian; Xiaoliang Wang; Suli Zhang; Zhongmei He; Li Yan; Rongrui Zhao; Xin L. Ma; Huirong Liu
BACKGROUND β1-adrenoceptors (β1-ARs) are the predominant receptors in regulating heart functions. β1-ARs contain 7-transmembrane domains (7TM), 3 extracellular loops and 3 intracellular loops. Among these loops, the second extracellular loop of β1-AR (β1-AR-ECII) plays an important role in the pathogenesis of heart failure. METHODS (1) Select the sera-negative rats for antibodies against β1-AR-ECII. (2) Detect the level of antibodies against β1-AR-ECII in the process of active immunization with artificial synthetic peptides according to the sequence of human β1-AR-ECII. (3) Observe its long-term role on cardiac structure and function in vivo by immunizing rats. (4) Detect the changes of T lymphocytes subsets in the process of active immunization. RESULTS The peptides induced the production of specific autoantibody against β1-AR-ECII. Furthermore, immunization with β1-AR-ECII peptide induced both morphological and functional alterations in the hearts of rats, which potentially results in heart failure. In addition, induction of the autoantibodies against β1-AR-ECII increased the CD4+/CD8+ ratio in the peripheral blood of rats. DISCUSSION In this study, we determined the effect of anti-β1-AR-ECII autoantibody on morphological and functional cardiomyopathic alterations by immunization of rats with a synthetic peptide corresponding to the β1-AR-ECII for 18 months. These results provide further evidence that autoantibody against β1-AR-ECII is involved in the pathogenesis of heart failure. But the underlying mechanisms need further study.
Acta Pharmacologica Sinica | 2010
Jue Tian; Zi Yan; Ye Wu; Su-li Zhang; Ke Wang; Xiurui Ma; Li Guo; Jin Wan Wang; Lin Zuo; Jingyi Liu; Lin Quan; Huirong Liu
AbstractAim:To examine whether iNOS contributes to endothelial dysfunction in aged rats.Methods:Male Sprague Dawley rats were divided into three groups: young rats, aged rats treated with vehicle and aged rats treated with N-[3-(Aminomethyl) benzyl] acetamidine (1400W, 1 mg/kg, ip). Vasorelaxation was measured in isolated thoracic aorta. iNOS expression of thoracic aortic arteries was detected using immunohistochemistry and Western blot. Nitrotyrosine (a marker for peroxynitrite formation) content and expression in thoracic aortic tissue were determined using enzyme linked immunosorbent assay and immunohistochemistry.Results:Maximal relaxation induced by acetylcholine (10-9 to 10-5 mol/L) in the aged rats treated with vehicle was significantly decreased (70%±15%, P<0.01), as compared with the young rats (95%±8%). However, the maximal relaxation induced by acidified NaNO2 (an endothelium-independent vasodilator) had no significant difference between the two groups. Moreover, iNOS and nitrotyrosine expression increased in the vessels of the aged rats. In the aged rats treated with 1400W (a highly selective iNOS inhibitor) nitrotyrosine expression was reduced and acetylcholine-induced vasorelaxation was markedly improved (maximal relaxation was increased to 87%±8%, P<0.05), but the acidified NaNO2-induced vasorelaxation had no significant change.Conclusion:Our study demonstrated that inhibition of iNOS by 1400W increased endothelium-dependent vasodilation in aged rats. The mechanism was related with attenuation of peroxynitrite formation.
Archive | 2012
Huirong Liu; Ke Wang; Xiaoliang Wang; Jue Tian; Jianqin Jiao; Kehua Bai; Jie Yang; Haibo Xu
Globally, the proportion of elderly people is growing faster than any other age group. In 2000, one in ten, or about 600 million, people were 60 years or older. By 2025, it is expected to reach 1.2 billion people, and in 2050 around 1.9 billion (Hutton, 2008). Aging is a multifactorial process and has been defined as a time-dependent general decline in physiological function of an organism associated with a progressively increasing risk of morbidity and mortality. It is apparent that during aging different organs are losing their functional reserve and plasticity and become less able to fulfill their physiological function, especially under conditions of stress (Beneke & Burkle, 2007).
Age | 2013
Ke Wang; Jie Zhang; Jingyi Liu; Jue Tian; Ye Wu; Xiaoliang Wang; Lin Quan; Haibo Xu; Wen Wang; Huirong Liu
Journal of Cellular Physiology | 2013
Suli Zhang; Ronghua Zheng; Lihong Yang; Xi Zhang; Lin Zuo; Xiaoli Yang; Kehua Bai; Li Song; Jue Tian; Jie Yang; Huirong Liu
Antioxidants & Redox Signaling | 2012
Suli Zhang; Xi Zhang; Lihong Yang; Zi Yan; Li Yan; Jue Tian; Xiaoyu Li; Li Song; Li Wang; Xiaoli Yang; Ronghua Zheng; Wayne Bond Lau; Xin-Liang Ma; Huirong Liu
Basic Research in Cardiology | 2009
Li Yan; Yanwu Xu; Hong Yao; Wenxin Xue; Jue Tian; Haiqiang Ren; Ye Wu; Guangzhao Yang; Xin L. Ma; Huirong Liu
International Journal of Cardiology | 2014
Lin Zuo; Haijun Bao; Jue Tian; Xiaoliang Wang; Suli Zhang; Zhongmei He; Li Yan; Rongrui Zhao; Xin L. Ma; Huirong Liu
The FASEB Journal | 2007
Jue Tian; Jia Jia; Ye Wu; Xiaoli Yang; Xiao-Ping Lv; Xin-Liang Ma; Huirong Liu
Cardiovascular Toxicology | 2017
Ye Wu; Xiutao Tan; Jue Tian; Xin Liu; Yehong Wang; Huanxin Zhao; Zi Yan; Huirong Liu; Xin-Liang Ma